Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001404644-25-000068
Filing Date
2025-06-13
Accepted
2025-06-13 12:07:42
Documents
3
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749830856.html 4  
1 FORM 4 wk-form4_1749830856.xml 4 3938
2 EX-24 ngnesection16poa_rbaffix.htm EX-24 4232
3 ngnesection16poa_rbaffix001.jpg GRAPHIC 219062
  Complete submission text file 0001404644-25-000068.txt   311753
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
BAFFI ROBERT (Reporting) CIK: 0001274826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 251045336

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)